Nurix Obtains $17,033,334 New Funding

  • Feed Type
  • Date
    9/18/2015
  • Company Name
    Nurix
  • Mailing Address
    1700 Owens Street San Francisco, CA 94158 USA
  • Company Description
    The company is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.
  • Website
    http://www.nurix-inc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,033,334
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds are to be used for working capital. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy